Valeo Pharma Inc.

TSX:VPH 株式レポート

時価総額:CA$4.4m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Valeo Pharma マネジメント

マネジメント 基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Al Moghaddam

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間less than a year
CEOの所有権n/a
経営陣の平均在職期間1.6yrs
取締役会の平均在任期間1.8yrs

経営陣の近況

Recent updates

Market Might Still Lack Some Conviction On Valeo Pharma Inc. (TSE:VPH) Even After 55% Share Price Boost

Jun 14
Market Might Still Lack Some Conviction On Valeo Pharma Inc. (TSE:VPH) Even After 55% Share Price Boost

Market Cool On Valeo Pharma Inc.'s (TSE:VPH) Revenues Pushing Shares 31% Lower

Apr 20
Market Cool On Valeo Pharma Inc.'s (TSE:VPH) Revenues Pushing Shares 31% Lower

Valeo Pharma Inc. (TSE:VPH) Stocks Pounded By 33% But Not Lagging Industry On Growth Or Pricing

Mar 02
Valeo Pharma Inc. (TSE:VPH) Stocks Pounded By 33% But Not Lagging Industry On Growth Or Pricing

Investors Still Aren't Entirely Convinced By Valeo Pharma Inc.'s (TSE:VPH) Revenues Despite 68% Price Jump

Jan 17
Investors Still Aren't Entirely Convinced By Valeo Pharma Inc.'s (TSE:VPH) Revenues Despite 68% Price Jump

Valeo Pharma Inc. (TSE:VPH) Might Not Be As Mispriced As It Looks After Plunging 29%

Jun 08
Valeo Pharma Inc. (TSE:VPH) Might Not Be As Mispriced As It Looks After Plunging 29%

Analysts Have Just Cut Their Valeo Pharma Inc. (TSE:VPH) Revenue Estimates By 24%

Jun 24
Analysts Have Just Cut Their Valeo Pharma Inc. (TSE:VPH) Revenue Estimates By 24%

Earnings Update: Valeo Pharma Inc. (TSE:VPH) Just Reported And Analysts Are Trimming Their Forecasts

Jun 17
Earnings Update: Valeo Pharma Inc. (TSE:VPH) Just Reported And Analysts Are Trimming Their Forecasts

Have Insiders Been Buying Valeo Pharma Inc. (CSE:VPH) Shares This Year?

Feb 08
Have Insiders Been Buying Valeo Pharma Inc. (CSE:VPH) Shares This Year?

CEO(最高経営責任者

Al Moghaddam (57 yo)

less than a year

在職期間

Mr. Al Moghaddam, B. Com. CMA had been a Director at Valeo Pharma Inc. since March 21, 2024 until June 2024 and served as its Chief Development Officer since June 2024 until August 2024 and serves as its C...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Kyle Steiger
Senior VP & Chief Commercial Officer2.3yrsCA$388.21k0.020%
CA$ 872.5
Al Moghaddam
Chief Executive Officerless than a yearデータなしデータなし
Pascal Tougas
Chief Financial Officerless than a yearデータなしデータなし
Frédéric Dumais
Director of Communications & Investor Relationsno dataデータなしデータなし
Guy-Paul Allard
VP of Legal Affairs & Corporate Secretaryno dataデータなし0%
CA$ 0
Jean Fournier
Head of Ophthalmology Business Unit2.3yrsデータなしデータなし

1.6yrs

平均在職期間

経験豊富な経営陣: VPHの経営陣は 経験豊富 とはみなされません ( 1.6年の平均在職年数)。これは新しいチームを示唆しています。


取締役

名称ポジション在職期間報酬所有権
Robert Raich
Independent Directorless than a yearデータなし0.18%
CA$ 7.9k
Richard MacKay
Chairman of the Advisory Board & Director15.8yrsデータなし16.44%
CA$ 730.0k
Steven Saviuk
Chairman21.7yrsCA$466.29k0.18%
CA$ 8.1k
Marc Leger
Independent Non-Executive Director2.6yrsデータなし2.36%
CA$ 104.9k
Richard Lajoie
Independent Directorless than a yearデータなしデータなし
Charles Bisaillon
Independent Directorless than a yearデータなしデータなし

1.8yrs

平均在職期間

65yo

平均年齢

経験豊富なボード: VPHの 取締役会経験豊富 ではない ( 1.8年の平均在任期間) ため、新しい取締役会が必要であると考えられます。